Literature DB >> 22754076

An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda.

Narendra Singh1, Mohit Bhalla, Prashanti de Jager, Marilena Gilca.   

Abstract

Withania somnifera (Ashawagandha) is very revered herb of the Indian Ayurvedic system of medicine as a Rasayana (tonic). It is used for various kinds of disease processes and specially as a nervine tonic. Considering these facts many scientific studies were carried out and its adaptogenic / anti-stress activities were studied in detail. In experimental models it increases the stamina of rats during swimming endurance test and prevented adrenal gland changes of ascorbic acid and cortisol content produce by swimming stress. Pretreatment with Withania somnifera (WS) showed significance protection against stress induced gastric ulcers. WS have anti-tumor effect on Chinese Hamster Ovary (CHO) cell carcinoma. It was also found effective against urethane induced lung-adenoma in mice. In some cases of uterine fibroids, dermatosarcoma, long term treatment with WS controlled the condition. It has a Cognition Promoting Effect and was useful in children with memory deficit and in old age people loss of memory. It was also found useful in neurodegenerative diseases such as Parkinson's, Huntington's and Alzeimer's diseases. It has GABA mimetic effect and was shown to promote formation of dendrites. It has anxiolytic effect and improves energy levels and mitochondrial health. It is an anti-inflammatory and anti-arthritic agent and was found useful in clinical cases of Rheumatoid and Osteoarthritis. Large scale studies are needed to prove its clinical efficacy in stress related disorders, neuronal disorders and cancers.

Entities:  

Keywords:  Withania somnifera; adaptogen / anti-stress; anti-arthritic; anti-tumor; neuroregenerative; rejuvenator

Mesh:

Substances:

Year:  2011        PMID: 22754076      PMCID: PMC3252722          DOI: 10.4314/ajtcam.v8i5S.9

Source DB:  PubMed          Journal:  Afr J Tradit Complement Altern Med        ISSN: 2505-0044


  9 in total

1.  Antistressor effect of Withania somnifera.

Authors:  R Archana; A Namasivayam
Journal:  J Ethnopharmacol       Date:  1999-01       Impact factor: 4.360

2.  Effect of Withania somnifera on glycosaminoglycan synthesis in carrageenin-induced air pouch granuloma.

Authors:  V H Begum; J Sadique
Journal:  Biochem Med Metab Biol       Date:  1987-12

Review 3.  Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review.

Authors:  L C Mishra; B B Singh; S Dagenais
Journal:  Altern Med Rev       Date:  2000-08

4.  The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer's disease.

Authors:  T C Dickson; J C Vickers
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  Contributions to the pharmacodynamic study of roots of Withania somnifera Dun species of Pakistani origin. Note III: Testing of analgesic activity of dichlormethanic and methanolic extract from Withania somnifera roots.

Authors:  E Sakka Mazen; M Pavelescu; E Grigorescu
Journal:  Rev Med Chir Soc Med Nat Iasi       Date:  1990 Oct-Dec

6.  The effect of aqueous extracts of Cynomorium coccineum and Withania somnifera on testicular development in immature Wistar rats.

Authors:  E M Abdel-Magied; H A Abdel-Rahman; F M Harraz
Journal:  J Ethnopharmacol       Date:  2001-04       Impact factor: 4.360

7.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: correlation with cognitive severity.

Authors:  S T DeKosky; S W Scheff
Journal:  Ann Neurol       Date:  1990-05       Impact factor: 10.422

8.  An animal model for coexisting tardive dyskinesia and tardive parkinsonism: a glutamate hypothesis for tardive dyskinesia.

Authors:  L M Gunne; P E Andrén
Journal:  Clin Neuropharmacol       Date:  1993-02       Impact factor: 1.592

9.  Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration.

Authors:  Tomoharu Kuboyama; Chihiro Tohda; Katsuko Komatsu
Journal:  Eur J Neurosci       Date:  2006-03       Impact factor: 3.386

  9 in total
  67 in total

1.  Withaferin A Analogs That Target the AAA+ Chaperone p97.

Authors:  Shasha Tao; Joseph Tillotson; E M Kithsiri Wijeratne; Ya-Ming Xu; MinJin Kang; Tongde Wu; Eric C Lau; Celestina Mesa; Damian J Mason; Robert V Brown; James J La Clair; A A Leslie Gunatilaka; Donna D Zhang; Eli Chapman
Journal:  ACS Chem Biol       Date:  2015-06-03       Impact factor: 5.100

2.  A Pragmatic Approach to Immunity & Respiratory Viral Infections.

Authors:  Todd A Born
Journal:  Integr Med (Encinitas)       Date:  2020-10

3.  Withania somnifera as a Potential Anxiolytic and Anti-inflammatory Candidate Against Systemic Lipopolysaccharide-Induced Neuroinflammation.

Authors:  Muskan Gupta; Gurcharan Kaur
Journal:  Neuromolecular Med       Date:  2018-05-30       Impact factor: 3.843

4.  Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract: A Double-Blind, Randomized, Placebo-Controlled Trial.

Authors:  Dnyanraj Choudhary; Sauvik Bhattacharyya; Kedar Joshi
Journal:  J Evid Based Complementary Altern Med       Date:  2016-04-06

5.  Phytochemicals and botanical extracts regulate NF-κB and Nrf2/ARE reporter activities in DI TNC1 astrocytes.

Authors:  Deepa Ajit; Agnes Simonyi; Runting Li; Zihong Chen; Mark Hannink; Kevin L Fritsche; Valeri V Mossine; Robert E Smith; Thomas K Dobbs; Rensheng Luo; William R Folk; Zezong Gu; Dennis B Lubahn; Gary A Weisman; Grace Y Sun
Journal:  Neurochem Int       Date:  2016-05-07       Impact factor: 3.921

6.  Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.

Authors:  Dong Wook Lim; Jae Goo Kim; Eun Yeong Lim; Yun Tai Kim
Journal:  Inflammopharmacology       Date:  2017-08-28       Impact factor: 4.473

Review 7.  An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera).

Authors:  Morgan A Pratte; Kaushal B Nanavati; Virginia Young; Christopher P Morley
Journal:  J Altern Complement Med       Date:  2014-12       Impact factor: 2.579

8.  Oral supplementation of standardized extract of Withania somnifera protects against diabetes-induced testicular oxidative impairments in prepubertal rats.

Authors:  Chandrashekara Nagaraj Kyathanahalli; Mallayya Jayawanth Manjunath
Journal:  Protoplasma       Date:  2014-02-01       Impact factor: 3.356

9.  Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells.

Authors:  Grace Y Sun; Runting Li; Jiankun Cui; Mark Hannink; Zezong Gu; Kevin L Fritsche; Dennis B Lubahn; Agnes Simonyi
Journal:  Neuromolecular Med       Date:  2016-05-21       Impact factor: 3.843

Review 10.  Pharmacologic overview of Withania somnifera, the Indian Ginseng.

Authors:  Nawab John Dar; Abid Hamid; Muzamil Ahmad
Journal:  Cell Mol Life Sci       Date:  2015-08-26       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.